4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Madrigal Pharmaceuticals, Inc. (MDGL) operates in the Biotechnology industry and is headquartered in West Conshohocken, United States with about 915 employees. Its market capitalization is roughly $13 billion. In the fiscal year ended 2025-12-31, MDGL reported $958M in revenue and ($288M) in net income.
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH.
Interactive charts & full statements → Open the MDGL valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $958M | $180M | $0M | $0M | — |
| Gross Profit | $902M | $174M | $0M | $0M | — |
| Operating Income (EBIT) | ($300M) | ($498M) | ($380M) | ($294M) | — |
| Net Income | ($288M) | ($466M) | ($374M) | ($295M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $311M | $321M | $287M | $213M | $137M |
| Gross Profit | $284M | $297M | $269M | $204M | $133M |
| Operating Income (EBIT) | ($93M) | ($60M) | ($114M) | ($47M) | ($79M) |
| Net Income | ($94M) | ($59M) | ($114M) | ($42M) | ($73M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.3B | $1.0B | $640M | $363M | — |
| Total Liabilities | $657M | $288M | $235M | $165M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDGL viewer.
About TickerBase · Data methodology & sources